OBJECTIVE DIFFERENCES BETWEEN OVERACTIVE BLADDER PATIENTS WITH AND WITHOUT URODYNAMICALLY PROVEN DETRUSOR OVERACTIVITY

被引：0
|
作者：
Guralnick, Michael [1 ]
Grimsby, Gwen [1 ]
Liss, Michael [1 ]
Szabo, Aniko [1 ]
O'Connor, R. Corey [1 ]
机构：
[1] Med Coll Wisconsin, Milwaukee, WI 53226 USA
来源：
NEUROUROLOGY AND URODYNAMICS | 2009年 / 28卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：146 / 146
页数：1
相关论文
共 50 条
  • [41] Botulinum toxin treatment for overactive bladder and detrusor overactivity in adults
    Tincello, Douglas G.
    WORLD JOURNAL OF UROLOGY, 2012, 30 (04) : 451 - 456
  • [42] Is Intradetrusor OnabotulinumtoxinA more Successful in Patients with Urodynamically Observed Detrusor Overactivity?
    Butler, B.
    Murarka, S.
    Baker, M.
    Biller, D.
    INTERNATIONAL UROGYNECOLOGY JOURNAL, 2022, 33 (SUPPL 2) : S446 - S447
  • [43] Overactive Bladder Syndrome and Detrusor Overactivity: Is There a Strong Relation between the Symptoms and Urodynamic Findings?
    Zorba, Orhan Uenal
    Kocak, Taner
    Onem, Kadir
    TURKISH JOURNAL OF MEDICAL SCIENCES, 2009, 39 (02) : 267 - 272
  • [44] The prevalence of detrusor overactivity amongst patients with symptoms of overactive bladder: a retrospective cohort study
    P. Diamond
    S. Hassonah
    M. Alarab
    D. Lovatsis
    H. P. Drutz
    International Urogynecology Journal, 2012, 23 : 1577 - 1580
  • [45] The prevalence of detrusor overactivity amongst patients with symptoms of overactive bladder: a retrospective cohort study
    Diamond, P.
    Hassonah, S.
    Alarab, M.
    Lovatsis, D.
    Drutz, H. P.
    INTERNATIONAL UROGYNECOLOGY JOURNAL, 2012, 23 (11) : 1577 - 1580
  • [46] PERCUTANEOUS AND TRANSCUTANEOUS TIBIAL NERVE STIMULATION IN TREATMENT OF PATIENTS WITH OVERACTIVE BLADDER WITHOUT DETRUSOR OVERACTIVITY, REFRACTORY TO ANTIMUSCARINICS.
    Krivoborodov, G.
    Tur, E.
    Efremov, N.
    Khachaturova, N.
    NEUROUROLOGY AND URODYNAMICS, 2017, 36 : S457 - S458
  • [47] Botox® for idiopathic overactive bladder patients refractory to antimuscarinic therapy in the absence of detrusor overactivity
    Gousse, A.
    Barboglio, P.
    Cohen, B.
    Rodriguez, D.
    Caruso, D.
    NEUROUROLOGY AND URODYNAMICS, 2008, 27 (07) : 724 - 725
  • [48] Insight into New Potential Targets for the Treatment of Overactive Bladder and Detrusor Overactivity
    Cerruto, M. A.
    Asimakopoulos, A. D.
    Artibani, W.
    Del Popolo, G.
    La Martina, M.
    Carone, R.
    Finazzi-Agro, E.
    UROLOGIA INTERNATIONALIS, 2012, 89 (01) : 1 - 8
  • [49] An Overview on Mixed Action Drugs for the Treatment of Overactive Bladder and Detrusor Overactivity
    Asimakopoulos, A. D.
    Cerruto, M. A.
    Del Popolo, G.
    La Martina, M.
    Artibani, W.
    Carone, R.
    Finazzi-Agro, E.
    UROLOGIA INTERNATIONALIS, 2012, 89 (03) : 259 - 269
  • [50] Botulinum-A toxin for treatment of overactive bladder without detrusor overactivity:: Urodynamic outcome and patient satisfaction
    Schulte-Baukloh, H
    Weiss, C
    Stolze, T
    Stürzebecher, B
    Knispel, HH
    UROLOGY, 2005, 66 (01) : 82 - 87
12345